H.P. Sleeboom
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Oncology top 2%
- Bone health and treatments
Papers in
- Oncology 16
- Bone health and treatments 14
- COVID-19 and healthcare impacts 2
-
- Parathyroid Disorders and Treatments 2
- Co-authors
- Roger von Moos (6 shared papers)Luís Heitor Costa (2 shared papers)Vera Hirsh (2 shared papers)David H. Henry (2 shared papers)François Goldwasser (2 shared papers)Saroj Vadhan‐Raj (1 shared paper)Giorgio V. Scagliotti (2 shared papers)Vânia Hungria (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Medical Decision Making (2 papers)Annals of Oncology (2 papers)European Journal of Cancer (2 papers)BMC Health Services Research (1 paper)
- Partner nations
- NetherlandsBelgiumPortugal
In The Last Decade
H.P. Sleeboom
25 papers receiving 3.2k citations
H.P. Sleeboom's Hit Papers
Peers
Comparison fields: 5 of 86
- Cancer Research 949
- Oncology 1.4k
- Orthopedics and Sports Medicine 207
- Pulmonary and Respiratory Medicine 576
- Genetics 486
Countries citing papers authored by H.P. Sleeboom
This map shows the geographic impact of H.P. Sleeboom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.P. Sleeboom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.P. Sleeboom more than expected).
Fields of papers citing papers by H.P. Sleeboom
This network shows the impact of papers produced by H.P. Sleeboom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.P. Sleeboom. The network helps show where H.P. Sleeboom may publish in the future.
Co-authors
The 25 scholars most cited alongside H.P. Sleeboom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma Hit paper breakdown → | 2011 | 972 |
| 2 | Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group Hit paper breakdown → | 2001 | 843 |
| 3 | 2003 | 620 | |
| 4 | 2012 | 285 | |
| 5 | 1993 | 168 | |
| 6 | 2011 | 116 | |
| 7 | 1987 | 80 | |
| 8 | 1982 | 64 | |
| 9 | 1986 | 56 | |
| 10 | 1996 | 50 | |
| 11 | 1992 | 43 | |
| 12 | 2016 | 42 | |
| 13 | 2016 | 23 | |
| 14 | 2015 | 20 | |
| 15 | 1988 | 9 | |
| 16 | 2008 | 7 | |
| 17 | 2016 | 7 | |
| 18 | 2022 | 5 | |
| 19 | 2010 | 4 | |
| 20 | 2008 | 3 |
About H.P. Sleeboom
H.P. Sleeboom is a scholar working on Oncology, Nephrology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 3.4k indexed citations. Recurring topics across this work include Bone health and treatments (14 papers), Bladder and Urothelial Cancer Treatments (3 papers), Parathyroid Disorders and Treatments (2 papers), COVID-19 and healthcare impacts (2 papers), Advanced Breast Cancer Therapies (2 papers), Breast Cancer Treatment Studies (2 papers), Patient-Provider Communication in Healthcare (2 papers) and Erythropoietin and Anemia Treatment (1 paper). The work is most often cited by research in Cancer Research (949 citations), Oncology (1.4k citations), Orthopedics and Sports Medicine (207 citations), Pulmonary and Respiratory Medicine (576 citations) and Genetics (486 citations). H.P. Sleeboom has collaborated with scholars based in Netherlands, Belgium and Portugal. Frequent co-authors include Roger von Moos, Luís Heitor Costa, Vera Hirsh, David H. Henry, François Goldwasser, Saroj Vadhan‐Raj, Giorgio V. Scagliotti, Vânia Hungria, Andrew G Spencer and Jana Prausová. Their work appears in journals such as Journal of Clinical Oncology, Medical Decision Making, Annals of Oncology, European Journal of Cancer and BMC Health Services Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.